Mishima, Japan

Yasuhiko Ueno




Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Shizuoka, JP (1991)
  • Mishima, JP (2001 - 2012)

Company Filing History:


Years Active: 1991-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yasuhiko Ueno: Innovator in Chemical Stabilization

Introduction

Yasuhiko Ueno is a notable inventor based in Mishima, Japan. He has made significant contributions to the field of chemical stabilization, holding a total of 3 patents. His work focuses on innovative methods that enhance the stability of various compounds, particularly in pharmaceutical applications.

Latest Patents

One of Ueno's latest patents is a method of stabilizing diarylvinylene compounds. This invention provides a method for stabilization of a diarylvinylene compound, which may include a pharmaceutically acceptable salt in a solid formulation. The method involves the presence of an inorganic substance and/or a colorant in the solid formulation. Another significant patent is related to a solid dispersion dosage form of an amorphous xanthine derivative combined with an enteric-coating polymer. This invention addresses the formulation of a solid dispersion that includes a xanthine derivative and a polymer, enhancing its pharmacological properties.

Career Highlights

Throughout his career, Ueno has worked with prominent companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has contributed to his expertise in chemical formulations and stabilization techniques.

Collaborations

Ueno has collaborated with notable colleagues, including Tomoaki Masada and Yasuhiro Ishikawa. These partnerships have fostered innovation and development in his research endeavors.

Conclusion

Yasuhiko Ueno's contributions to the field of chemical stabilization through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…